论文部分内容阅读
目的:探讨急性心梗溶栓后再灌注性心律失常的发生情况以及冠脉再灌注的临床意义。方法选取我院2013年6月~2014年6月收治的68例急性心肌梗塞患者为研究对象,按是否符合冠脉再通标准将其分为再灌注组(38例)与未灌注组(30例)。比较两组患者心律失常的发生情况和心脏事件的发生率。结果两组患者心律失常的发生率比较差异无统计学意义(P>0.05),再灌注组加速性室性自主心律、窭性心动过缓、房室传导阻滞及束支阻滞的发生率明显高于未灌注组,比较差异均具有统计学意义(P<0.05)。再灌注组梗塞后心绞痛、再发心肌梗塞、心力衰竭、死亡等心脏性事件的发生率均低于未灌注组,比较差异具有统计学意义(P<0.05)。结论冠脉再灌注可缩小梗塞范围,降低患者的病死率,对于提高急性心肌梗塞的治疗水平具有积极意义。
Objective: To investigate the incidence of reperfusion arrhythmia after thrombolysis in acute myocardial infarction and the clinical significance of coronary reperfusion. Methods Sixty-eight patients with acute myocardial infarction admitted from June 2013 to June 2014 in our hospital were enrolled in this study. Patients were divided into two groups: reperfusion group (38 cases) and non-perfusion group (30 cases) example). The incidence of arrhythmia and the incidence of cardiac events in both groups were compared. Results There was no significant difference in the incidence of arrhythmia between the two groups (P> 0.05). The incidence of bradycardia, bradycardia, atrioventricular block and bundle branch block in reperfusion group Significantly higher than the non-perfusion group, the difference was statistically significant (P <0.05). The incidence of post-infarction angina pectoris, recurrent myocardial infarction, heart failure, death and other cardiac events in reperfusion group were significantly lower than those in non-perfusion group (P <0.05). Conclusion Coronary reperfusion can reduce the infarct size and reduce the mortality of patients, which has positive significance for improving the treatment of acute myocardial infarction.